Intrinsic Value of S&P & Nasdaq Contact Us

Cloud DX Inc. CDXFF OTC

Other OTC • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
24/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Cloud DX Inc. (CDXFF) is a publicly traded company in the Healthcare sector, operating within the Medical - Healthcare Information Services industry. The company is headquartered in Kitchener, NY, United States. The current CEO is Robert Manson Kaul.

CDXFF has IPO date of 2021-06-07, listed on the Other OTC, a market capitalization of $9.75M.

About Cloud DX Inc.

Cloud DX Inc. operates as a remote patient monitoring company. It offers Cloud DX Connected Health, an end-to-end virtual healthcare platform for monitoring patients with chronic illness, including chronic obstructive pulmonary disease and congestive heart failure, as well as patients recovering from surgery and COVID-19 patients outside hospitals. The company's Cloud DX Connected Health Kits includes its Cloud DX Bluetooth pulse oximeter, the Cloud DX wireless weight scale and optionally, a wireless Bluetooth blood pressure monitor, digital thermometer, and digital wireless glucose meter from 3rd party suppliers. It serves academic institutions, large hospitals, and provincial health authorities in Canada, as well as physician practices and hospitals in the United States. The company also offers VITALITI, a vital sign monitor for measuring electrocardiograph, heart rate, oxygen saturation, respiration, core body temperature, blood pressure, movement, steps, and posture. Cloud DX Inc. is headquartered in Brooklyn, New York.

📍 834-20 Jay Street, Kitchener, NY 11201 📞 888 543 0944
Company Details
SectorHealthcare
IndustryMedical - Healthcare Information Services
CountryUnited States
ExchangeOther OTC
CurrencyUSD
IPO Date2021-06-07
CEORobert Manson Kaul
Trading Info
Current Price$0.09
Market Cap$9.75M
52-Week Range0.084-0.0945
Beta0.44
ETFNo
ADRNo
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message